United Therapeutics (NASDAQ:UTHR) Stock Rating Upgraded by Bank of America
United Therapeutics (NASDAQ:UTHR – Get Free Report) was upgraded by investment analysts at Bank of America from an “underperform” rating to a “neutral” rating in a note issued to investors on Monday, Marketbeat Ratings reports. The firm currently has a $314.00 price target on the biotechnology company’s stock. Bank of America‘s target price points to […]
United Therapeutics (NASDAQ:UTHR – Get Free Report) was upgraded by investment analysts at Bank of America from an “underperform” rating to a “neutral” rating in a note issued to investors on Monday, Marketbeat Ratings reports. The firm currently has a $314.00 price target on the biotechnology company’s stock. Bank of America‘s target price points to […]
